Main Text {#sec1}
=========

We live in paradoxical times. The COVID-19 pandemic is physically isolating us, but it is increasingly clear that collaboration and collective action are the most powerful tools to combat this crisis.

As we head into the ISSCR annual meeting, a time when the global stem cell community typically gathers to exchange ideas, expand our networks, and inspire each other to push the boundaries of what stem cell science can accomplish, we are asking ourselves how we can adapt to promote scientific progress at this unprecedented moment in our lifetimes.

What does that mean at *Cell Stem Cell*? {#sec1.1}
----------------------------------------

Our editorial values are to be rigorous, fair, and decisive in our approach to peer review. We try to engage in productive dialog with authors, reviewers, and readers to support our efforts. These principles guide the changes we are making in response to the current crisis. Here we share some answers to frequent questions we are receiving from the stem cell community.

Is *Cell Stem Cell* still operating as normal? How has the COVID-19 crisis affected the journal? {#sec1.2}
------------------------------------------------------------------------------------------------

We are fortunate that our work can largely be accomplished remotely. We've had to adjust to our new home working environments, but our editorial, production, and support staff are all safely working from home in Cambridge, Boston, Philadelphia, Los Angeles, Shanghai, and other locations. Scientific energy in our community has remained high, and if anything, we've seen an increase in the number of manuscript submissions in recent months. We're actively recruiting papers that use stem cell technologies to address COVID-19-related problems. We also want to hear from you about the impact COVID-19 is having on your research program (see Voices and Q&A in this issue).

Many labs are closed to non-COVID-19-related research. How has this affected the expectations for my paper under review or revision? {#sec1.3}
------------------------------------------------------------------------------------------------------------------------------------

We understand that critical safety measures may affect your ability to conduct or finalize revisions. We are sympathetic to this challenge and to the urgency you feel to communicate research findings in a timely manner. If you find that there are some critiques on your manuscript that cannot be addressed experimentally, we encourage you to contact the handling editor for your manuscript to discuss them and we can work with you on a constructive revision plan. We can't rule out the need for additional experimental work, but we think that an open dialog is the best path for finding solutions. We have always been flexible with revision timing and understand the need for that in our current climate. If we can't come up with a plan that's achievable for you, we'll work with you to explore other publishing options at Cell Press.

We also understand the value of quickly making current research public and support the widespread use of preprint servers to share and build on research during the COVID-19 outbreak. For an issue like COVID-19 that has such high importance and interest to public safety, we encourage a particularly cautious approach to the description and interpretation of research findings, especially when they have not been considered through a rigorous peer review process. Papers under review at *Cell Stem Cell* can be deposited to Cell Press's Sneak Peek (<https://www.cell.com/sneakpeek>) for rapid dissemination, and we also consider manuscripts posted to external servers such as bioRxiv.

What is your message to reviewers during this time? Should I change my approach to reviewing papers in light of these circumstances? {#sec1.4}
------------------------------------------------------------------------------------------------------------------------------------

First and foremost, THANK YOU! We understand that you are busy, probably adjusting to home-based work, and likely taking on new personal and institutional responsibilities all at once. As a reviewer, your work takes place behind the scenes, but it certainly doesn't go unnoticed or unappreciated. We are truly grateful for all that you do to contribute to the journal and stem cell science. If you need more time to complete a review or are hesitant to take on an assignment because of these new challenges, we understand. We all have to be flexible as we adjust to new responsibilities and pressures on our time, so please talk to us so we can make arrangements that will work for you or so we can move on and seek input elsewhere.

We have been fielding many questions from reviewers about how to balance revision requests knowing that many labs are closed. We remain committed to publishing breakthrough papers with the high level of scientific rigor that our readers expect from *Cell Stem Cell*. Our philosophy toward peer review hasn't changed, but we are more vigilant than ever to hold ourselves and reviewers accountable to reasonable expectations for revisions. In practice, this means that we can make accommodations relating to time, effort, and how much a given set of analyses will improve a paper, as long as the central conceptual and technological advances are not compromised.

How can I address open questions, alternative interpretations, and experimental caveats directly in my paper? {#sec1.5}
-------------------------------------------------------------------------------------------------------------

Good science leads to more questions. We know you can't address every possible critique or question in a single study, and many questions should be explored in future manuscripts. The current crisis and our strict guidance to reviewers has made this even more clear to us. We are borrowing from the playbook of our colleagues at *Cell Metabolism* and introducing a Discussion subsection dedicating to addressing the "Limitations of Study" (<https://www.cell.com/cell-stem-cell/authors>) to more clearly outline these issues.

What is Cell Press doing to contribute to the research efforts on COVID-19? {#sec1.6}
---------------------------------------------------------------------------

The scientific community is coming together in unprecedented fashion to work collaboratively on this global health problem. Cell Press has launched a [Coronavirus Resource Hub](https://www.cell.com/COVID-19){#intref0020} to quickly and broadly disseminate published research findings on SARS-CoV-2 and COVID-19. Proofs of papers appear on this hub shortly after acceptance. The information is freely accessible throughout the pandemic. Our parent company Elsevier has made over 20,000 coronavirus-related papers freely available at this [novel coronavirus information center](https://www.elsevier.com/connect/coronavirus-information-center){#intref0025} and have [committed along with other publishers](https://www.elsevier.com/connect/coronavirus-information-center){#intref0030} to submit these papers to PubMed Central and other health database repositories so that they are more readily searchable.

Are *Cell Stem Cell* editors attending ISSCR 2020 Virtual? How can we connect with journal editors during this period of social distancing? {#sec1.7}
-------------------------------------------------------------------------------------------------------------------------------------------

Conference attendance is one of our favorite activities, and we are disappointed about all the missed opportunities to connect directly with stem cell scientists this year. There are other ways for us to connect, including at ISSCR 2020 Virtual. We're holding several virtual "Meet-the-Editors" sessions during the conference (<https://www.cell.com/isscr-meet-the-editor-2020>). These will be digital one-on-one video meetings held through Microsoft Teams. We encourage you to book an appointment to discuss your latest research with us, get input on a paper, ask questions about our editorial policies, or just introduce yourself and get to know us. At any time (conference or not) if you're looking for feedback about a potential submission about a manuscript in preparation, you can always email us with a presubmission inquiry or use the form at <http://info.cell.com/cell-stem-cell-presubmission-inquiry>.
